These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 2562495

  • 1. The clinical utility of pharmacological agents that act at serotonin receptors.
    Peroutka SJ, Sleight AJ, McCarthy BG, Pierce PA, Schmidt AW, Hekmatpanah CR.
    J Neuropsychiatry Clin Neurosci; 1989; 1(3):253-62. PubMed ID: 2562495
    [Abstract] [Full Text] [Related]

  • 2. Serotonin receptor and reuptake sites: pharmacologic significance.
    Gonzalez-Heydrich J, Peroutka SJ.
    J Clin Psychiatry; 1990 Apr; 51 Suppl():5-12; discussion 13. PubMed ID: 2157701
    [Abstract] [Full Text] [Related]

  • 3. Serotonin receptor subtypes: implications for psychopharmacology.
    Cowen PJ.
    Br J Psychiatry Suppl; 1991 Sep; (12):7-14. PubMed ID: 1840764
    [Abstract] [Full Text] [Related]

  • 4. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].
    Moulignier A.
    Rev Neurol (Paris); 1994 Sep; 150(1):3-15. PubMed ID: 7801037
    [Abstract] [Full Text] [Related]

  • 5. Serotonin: a common neurobiologic substrate in anxiety and depression.
    Eison MS.
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):26S-30S. PubMed ID: 2198299
    [Abstract] [Full Text] [Related]

  • 6. Serotonin dysfunction syndromes: a functional common denominator for classification of depression, anxiety, and obsessive-compulsive disorder.
    Benkert O, Wetzel H, Szegedi A.
    Int Clin Psychopharmacol; 1993 Sep; 8 Suppl 1():3-14. PubMed ID: 8254151
    [No Abstract] [Full Text] [Related]

  • 7. Serotonin receptors--where are they going?
    Leonard BE.
    Int Clin Psychopharmacol; 1994 Mar; 9 Suppl 1():7-17. PubMed ID: 8021439
    [Abstract] [Full Text] [Related]

  • 8. [Behavior of 5-HT receptors during long-term antidepressant treatment and at discontinuation].
    Fillion G.
    Encephale; 1995 Feb; 21 Spec No 1():3-6. PubMed ID: 7729352
    [No Abstract] [Full Text] [Related]

  • 9. The antidepressant effects of 5-HT uptake inhibitors.
    Aberg-Wistedt A.
    Br J Psychiatry Suppl; 1989 Dec; (8):32-40. PubMed ID: 2692638
    [Abstract] [Full Text] [Related]

  • 10. [Potential value of 5-HT2 receptor antagonists in the treatment of dysthymic disorders].
    Sechter D, Bonin B, Bizouard P.
    Encephale; 1992 Dec; 18 Spec No 5():753-4. PubMed ID: 1342678
    [No Abstract] [Full Text] [Related]

  • 11. [Central serotonin receptors and chronic treatment with selective serotonin reuptake inhibitors in the rat: comparative effects of fluoxetine and paroxetine].
    Le Poul E, Lima L, Laporte AM, Even C, Doucet E, Fattaccini CM, Laaris N, Hamon M, Lanfumey L.
    Encephale; 1995 Dec; 21(2):123-32. PubMed ID: 7781583
    [Abstract] [Full Text] [Related]

  • 12. Serotonergic mechanisms and current and future psychiatric practice.
    Dubovsky SL, Thomas M.
    J Clin Psychiatry; 1995 Dec; 56 Suppl 2():38-48. PubMed ID: 7844106
    [Abstract] [Full Text] [Related]

  • 13. Serotonin-specific drugs for anxiety and depressive disorders.
    Charney DS, Krystal JH, Delgado PL, Heninger GR.
    Annu Rev Med; 1990 Dec; 41():437-46. PubMed ID: 2139556
    [Abstract] [Full Text] [Related]

  • 14. Serotonin receptors: subtypes, functional responses and therapeutic relevance.
    Saxena PR.
    Pharmacol Ther; 1995 May; 66(2):339-68. PubMed ID: 7667401
    [Abstract] [Full Text] [Related]

  • 15. Molecular and cellular mechanisms of antidepressant drugs.
    Owens MJ.
    Depress Anxiety; 1995 May; 4(4):153-9. PubMed ID: 9166647
    [Abstract] [Full Text] [Related]

  • 16. Role of serotonin in therapy of depression and related disorders.
    Fuller RW.
    J Clin Psychiatry; 1991 May; 52 Suppl():52-7. PubMed ID: 1674251
    [Abstract] [Full Text] [Related]

  • 17. A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence.
    Blier P, de Montigny C, Chaput Y.
    J Clin Psychiatry; 1990 Apr; 51 Suppl():14-20; discussion 21. PubMed ID: 2157700
    [Abstract] [Full Text] [Related]

  • 18. The marketing of 5-hydroxytryptamine: depression or anxiety?
    Healy D.
    Br J Psychiatry; 1991 Jun; 158():737-42. PubMed ID: 1873625
    [No Abstract] [Full Text] [Related]

  • 19. 5-Hydroxytryptamine facilitates cholinergic bronchoconstriction in human and guinea pig airways.
    Takahashi T, Ward JK, Tadjkarimi S, Yacoub MH, Barnes PJ, Belvisi MG.
    Am J Respir Crit Care Med; 1995 Jul; 152(1):377-80. PubMed ID: 7599849
    [Abstract] [Full Text] [Related]

  • 20. Opportunities for treatment of psychoactive substance use disorders with serotonergic medications.
    Sellers EM, Higgins GA, Tomkins DM, Romach MK, Toneatto T.
    J Clin Psychiatry; 1991 Dec; 52 Suppl():49-54. PubMed ID: 1752860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.